Skip to main content
. Author manuscript; available in PMC: 2019 Jun 3.
Published in final edited form as: Obstet Gynecol. 2010 Sep;116(3):583–593. doi: 10.1097/AOG.0b013e3181e9e0ab

Table 1.

Characteristics of Participants

Placebo-Placebo Lidocaine-Placebo Desipramine-Placebo Desipramine-Lidocaine P
Age (y) 33 (27.7±6.3) 32 (31.6±8.4) 32 (31.0±7.7) 34 (31.3 ±6.8) .11*
Duration of pain (y) 30 (5.9±6.3) 30 (5.8±5.7) 31 (4.4±3.7) 33 (6.5±7.0) .53*
Years of education 32 (16.3±3.0) 31 (16±3.0) 32 (16.4±2.4) 33 (15.6±3.4) .61*
Race
 White (non-Hispanic) 29 (0.88) 32 (1.00) 30 (0.94) 28 (0.82) .21
 Other 4 (0.12) 2 (0.06) 6 (0.18)
Currently married/partnered 22 (0.67) 23 (0.72) 26 (0.81) 28 (0.82) .53
Nullipara 26 (0.79) 24 (0.75) 23 (0.72) 28 (0.82) .76
Main problem
 Intercourse pain 22 (0.67) 21 (0.66) 25 (0.78) 23 (0.68) .92
 Spontaneous pain 7 (0.21) 8 (0.25) 5 (0.16) 10 (0.29) .44
Pain start
 After intercourse 7 (0.21) 6 (0.19) 5 (0.16) 10 (0.29) .40
 Yeast infection 2 (0.06) 7 (0.22) 3 (0.09) 4 (0.12) .37
 Surgical procedure 1 (0.03) 4 (0.13) 2 (0.06) 1 (0.03) .56
 Other 11 (0.33) 5 (0.16) 6 (0.19) 6 (0.18) .22
 Do not know 12 (0.36) 10 (0.31) 16 (0.50) 13 (0.38) .35
Prior vulvar pain therapy
 Antidepressant 4 (0.12) 10 (0.31) 4 (0.12) 4 (0.12) .10
 Lidocaine 10 (0.30) 14 (0.44) 13 (0.41) 11 (0.32) .62

Data are n (mean±σ) or n (%) unless otherwise specified: “—” indicates 0.

*

Analysis of variance.

χ2.

Fisher’s exact test.